Company intelligence / Profile preview

Lingotto Horizon

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Lingotto is an independent investment management firm owned by Exor, the holding company of the Agnelli family. The firm's 'Horizon' strategy, led by veteran investor James Anderson, focuses on long-term, high-conviction investments in transformative innovation, with a significant emphasis on the life sciences and healthcare sectors. Lingotto Horizon provides capital to both private and public companies, supporting advancements in areas such as gene therapy, brain health, and AI-driven drug discovery. The firm is headquartered in London and manages assets for institutional partners including Exor and Covéa.

Industry: Investors

Partnerships

Covéa

Beyond the preview

Go deeper on Lingotto Horizon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lingotto Horizon.

Explore the full profile